This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Foreign product alert

Get Stiff, Maxi Mize

Starting date:
January 25, 2012
Posting date:
January 25, 2012
Type of communication:
Foreign Product Alert (FPA)
Subcategory:
Natural health products
Source of recall:
Health Canada
Issue:
Undeclared Substance, Product Safety
Audience:
General Public
Identification number:
RA-120001761

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Source of alert

New Zealand's Medsafe

Product names

  • Get Stiff
  • Maxi Mize

Manufacturer / Place of origin

Unknown

Product description

Get Stiff and Maxi Mize are promoted as natural health products used for sexual enhancement.

Reason for warning

New Zealand's Medsafe warned consumers not to use these products after they were found to contain undeclared pharmaceutical ingredients, as follows.

Undeclared Pharmaceutical Ingredients
Product Undeclared Ingredient
Get Stiff
  • vardenafil - 6 mg
  • yohimbine - 2 mg
  • tadalafil - trace amounts
Maxi Mize
  • hydroxyhomosildenafil - 2 mg
  • hydroxythiohomosildenafil - 130 mg
  • tadalafil - trace amounts

Hydroxyhomosildenafil and hydroxythiohomosildenafil are unauthorized substances similar to sildenafil and may pose similar health risks. Sildenafil, vardenafil and tadalafil are prescription drugs used to treat erectile dysfunction and should only be taken under the supervision of a health care practitioner.

Yohimbine is a prescription drug used to treat abnormal blood pressure and should only be taken under the supervision of a health care practitioner.

Possible side effects

Sildenafil, vardenafil and tadalafil should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerine) as they can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side-effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heart beat. Other side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.

Side effects associated with yohimbine include abnormal blood pressure and heartbeat, anxiety, tremors, headache, nausea and sleep disorders.  

What you should do

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709

Images

Select thumbnail to enlarge - opens in a new window